NCT06504719 2025-09-15Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab GovitecanHellenic Cooperative Oncology GroupCompleted312 enrolled
NCT06462079 2024-06-17Sacituzumab Govitecan Combined With Head Radiotherapy for Her2-negative Breast Cancer Brain MetastasesGuangzhou Medical UniversityPhase 2 Not yet recruiting43 enrolled